Viewing Study NCT00515840



Ignite Creation Date: 2024-05-05 @ 6:36 PM
Last Modification Date: 2024-10-26 @ 9:35 AM
Study NCT ID: NCT00515840
Status: COMPLETED
Last Update Posted: 2015-11-05
First Post: 2007-08-13

Brief Title: GPIAG and Leicester Asthma and Dysfunctional Breathing GLAD Study a Randomised Controlled Study
Sponsor: P Burns
Organization: University of Aberdeen

Study Overview

Official Title: GPIAG and Leicester Asthma and Dysfunctional Breathing GLAD Study a Randomised Controlled Study
Status: COMPLETED
Status Verified Date: 2015-11
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: GLAD
Brief Summary: Breathing retraining supervised by a physiotherapist will result in improvements in the quality of life and asthma control of patients treated for asthma in the community with symptoms suggestive of dysfunctional breathing

To investigate the effects of breathing retraining on clinical and physiological parameters of asthma control to identify the characteristics of patients who benefit to perform a health economic evaluation
Detailed Description: Objectives

To assess the effect of breathing retraining on asthma-related health status asthma control and objective indices of asthma severity bronchial hyper-reactivity BHR sputum eosinophilia and nitric oxide production in patients with symptomatic asthma
To compare the relationship between symptoms of dysfunctional breathing Nijmegen Questionnaire screening score changes in asthma-related health status and other parameters resulting from breathing retraining
To explore the relationship between dysfunctional breathing baseline asthma symptoms treatment and asthma-related quality of life
To estimate the cost effectiveness of the breathing retraining intervention

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None